Replies to post #22461 on Arena Pharmaceuticals, Inc. (ARNA)

[FutureBankruptcy]

Leerink Swann began coverage on $ARNA in a report on Friday, May 19th. They issued an “outperform” rating and a $50.00 price target on the stock

https://sportsperspectives.com/2017/07/05/somewhat-negative-news-coverage-very-likely-to-impact-arena-pharmaceuticals-arna-share-price-updated.html

$ANRAN